TG Therapeutics Inc (TGTX)

Fixed asset turnover

		Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Revenue	US$ in thousands	221,047	2,785	6,689	152	152
Property, plant and equipment	US$ in thousands	95	307	600	481	282
Fixed asset turnover		2,326.81	9.07	11.15	0.32	0.54

December 31, 2023 calculation

Fixed asset turnover = Revenue ÷ Property, plant and equipment
= $221,047K ÷ $95K
= 2,326.81

TG Therapeutics Inc's fixed asset turnover ratio has exhibited significant fluctuations over the past five years. The ratio was remarkably high in the most recent year, standing at 2,326.81, indicating that the company generated $2,326.81 in sales for every $1 invested in fixed assets. This dramatic increase from the previous year's 9.07 suggests a substantial improvement in asset utilization efficiency.

In the earlier years, the fixed asset turnover ratio was also relatively high, with values of 11.15 in 2021 and 0.32 in 2020. The 2021 ratio implies that the company generated $11.15 in sales for each dollar invested in fixed assets, showcasing a strong efficiency in asset turnover. However, the significant drop in 2020 to 0.32 indicates a decrease in the utilization of fixed assets to generate sales, potentially signaling inefficiencies or underutilization of assets during that period.

The fixed asset turnover ratio for 2019 was 0.54, indicating a moderate level of asset turnover efficiency. Overall, the fluctuation in TG Therapeutics Inc's fixed asset turnover suggests varying levels of efficiency in utilizing fixed assets to generate sales over the past five years. It would be beneficial for the company to analyze the reasons behind these fluctuations and work towards maintaining a consistent and optimal level of asset turnover efficiency.